← Human Trials & Peer-Reviewed Studies
Effect of Exposure to e-Cigarettes With Salt vs Free-Base Nicotine on the Appeal and Sensory Experience of Vaping: A Randomized Clinical Trial.
Plain-language guide to PMID 33433597 (2021): double-blind randomized controlled trial of Therapeutic nicotine (patch, non-peptide) in 119 individuals.
Key Facts
- PMID
- 33433597
- Journal
- JAMA network open
- Year
- 2021
- Study type
- Randomized Controlled Trial
- Authors
- Leventhal AM et al. (10 authors)
- DOI
- 10.1001/jamanetworkopen.2020.32757
- Registered trial
- NCT04399031
What This Study Did, in Plain Language
What Was Tested
Researchers studied Therapeutic nicotine (patch, non-peptide) in this randomized controlled trial publication.
Alkaline free-base nicotine is bitter and a respiratory irritant.
Who Took Part
The study group was 119 individuals.
PubMed indexes the participants as adults, middle-aged adults and older adults, both men and women.
Single-visit double-blind within-participant randomized clinical trial was conducted in an academic medical center outpatient clinical research facility in Southern California.
Participants were 119 individuals with past 30-day e-cigarette or combustible cigarette use aged 21 years or older recruited from November 2019 to March 2020.
How the Study Was Run
The design is described as randomized and double-blind.
The individuals were allocated by chance, so the Therapeutic nicotine (patch, non-peptide) group and the comparison group should start out alike.
Blinding on both sides kept the individuals and researchers unaware of who received Therapeutic nicotine (patch, non-peptide).
Participants self-administered standardized puffs of each 10 differently flavored e-cigarette solutions using a pod-style device.
The 20 solutions were administered in randomly assigned sequences.
Immediately after puffing each solution, participants rated appeal and sensory attributes.
What Was Measured
PubMed files the paper under topics including California, Electronic Nicotine Delivery Systems, Nicotine, Sensation, Smokers and Vaping.
What This Means in Plain Language
The paper is a randomized and double-blind study of Therapeutic nicotine (patch, non-peptide) in 119 individuals.
Results are reported in around 7 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2021 (JAMA network open), a journal based in United States.
More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.
Our Notes on the Compound
Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.